Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.5099
+0.0079 (1.57%)
At close: Nov 6, 2026, 4:00 PM EST
0.50995
0.00 (0.01%)
After-hours: Nov 6, 2026, 7:58 PM EST
Valion Bio Market Cap
Valion Bio has a market cap or net worth of $452.58 thousand as of November 6, 2026. It is the 50,475th most valuable company in the world and the 6,928th biggest in the United States. Its market cap has decreased by 89.24% in one year.
Market Cap
452.58K
Enterprise Value
15.75M
1-Year Change
-89.24%
Global Rank
Country Rank
#6,928 United States
Category
ChartMarket Cap Chart
Since November 11, 2021, Valion Bio's market cap has decreased from $48.09M to $452.58K, a decrease of -99.06%. That is a compound annual growth rate of -60.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 452.58K | -87.64% |
| Dec 31, 2025 | 3.66M | 11.74% |
| Dec 31, 2024 | 3.28M | 24.22% |
| Dec 29, 2023 | 2.64M | -57.26% |
| Dec 30, 2022 | 6.17M | -83.58% |
| Dec 31, 2021 | 37.60M | -21.81% |
| Nov 11, 2021 | 48.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bone Biologics | 1.13M |
| Propanc Biopharma | 1.12M |
| Artelo Biosciences | 1.05M |
| Lakewood-Amedex Biotherapeutics | 915.41K |
| Silexion Therapeutics | 807.35K |
| Decoy Therapeutics | 740.29K |
| Virax Biolabs Group | 631.14K |
| Biodexa Pharmaceuticals | 318.95K |